Quality Control of Magistral (or in House or Smallscale) Produced Radiopharmaceuticals
PDF
Cite
Share
Request
Guideline
VOLUME: 6 ISSUE: 3
P: 275 - 283
November 2020

Quality Control of Magistral (or in House or Smallscale) Produced Radiopharmaceuticals

Nucl Med Semin 2020;6(3):275-283
1. Ege Üniversitesi Nükleer Bilimler Enstitüsü, Nükleer Uygulamalar Anabilim Dalı, İzmir, Türkiye
No information available.
No information available
PDF
Cite
Share
Request

ABSTRACT

As it is known, magistral radiopharmaceuticals are suitable for only in house use and are prepared, produced and supplied with a medical prescription for a certain patient in good laboratory practice (GLP) standard by a radiopharmacist. In this part of the guide; Information was provided on quality control methods and procedures for radiopharmacy employees involved in the quality control of magistrally manufactured radiopharmaceuticals. This document includes quality control methods and procedures for (F-18) NaF, Ge-68/Ga-68 Generator product Ga-68, Lu-177 obtained from reactor, (F-18) FDG, (Ga-68) DOTATOC, (Ga-68) PSMA, (Lu-177) DOTATATE, (Lu-177) PSMA, XOFIGO® [(Ra-223) RaCl2] and Sm-153-EDTMP.

Keywords:
Radiopharmaceuticals, magistral production, quality control

References

1
Ünak P, Altun DG, Teksöz S, Müftüler FZB. Applied Basic Radiopharmacy. Nobel Tıp Kitapevi, pp.179-185, 2017.
2
International Atomic Energy Agency, Good Practice For Introducing Radiopharmaceuticals For Clinical Use. IAEA-TECDOC Series No. IAEA-TECDOC-1782, Vienna, 2016. Available from: https://www.iaea.org/publications/10829/good-practice-for-introducing-radiopharmaceuticals-for-clinical-use
3
International Atomic Energy Agency, Operational Guidance On Hospital Radiopharmacy: A Safe And Effective Approach. IAEA, Vienna, 2004. Available from: https://www-pub.iaea.org/MTCD/Publications/PDF/Pub1342/Pub1342_web.pdf
4
International Atomic Energy Agency, Quality Control In The Production Of Radiopharmaceutical. IAEA-              TECDOC Series No. IAEA-TECDOC-1856, Vienna, 2018. Available from: https://www.iaea.org/publications/13422/quality-control-in-the-production-of-radiopharmaceuticals
5
International Atomic Energy Agency, Cyclotron Produced Radionuclides: Guidance on Facility Design and Production of [18F] Fluorodeoxyglucose (FDG). IAEA Radioisotopes And Radiopharmaceuticals Series, No.3, Vienna, 2012. Available from: https://www.eanm.org/content-eanm/uploads/2018/10/EANM_2018_TechGuide_ONLINE.pdf
6
Fendler WP, Eiber M, Beheshti M, et al. 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0. Eur J Nucl Med Mol Imaging 2017;44:1014-1024.
7
Prostate Cancer Imaging And Therapy. European Association of Nuclear Medicine Technolgist’s Guide, 2018. Available from: https://www.eanm.org/content-eanm/uploads/2018/10/EANM_2018_TechGuide_ONLINE.pdf
8
Radiopharmacy: An Update A Technologist’s Guide. European Association of Nuclear Medicine, 2019. Available from: https://www.eanm.org/publications/technologists-guide/radiopharmacy-an-update/